Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1825352-65-5
Formula :	C₂₂H₂₃N₇O
M.W :	401.46
SMILES Code :	O=C1C=C(C2=NN3C(C(C)=C2)=NC(C)=C3)N=C4N1C=C(N(C5)CCNC65CC6)C=C4
Synonyms :	RG7916; RO7034067; RO703406
MDL No. :	MFCD31657372
InChI Key :	ASKZRYGFUPSJPN-UHFFFAOYSA-N
Pubchem ID :	118513932

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Lymphoblastoid cell lines (LCLs)	636 nM	24 hours	To confirm the splice modulation effect of risdiplam on HTT, producing two major HTT alternative splice products	Nat Commun. 2024 Apr 12;15(1):3182.
MDCKII cells	1 µM	3.5 hours	To evaluate the passive permeability and transport properties of Risdiplam. Results showed that Risdiplam had an average passive permeability of around 350 nm/s in MDCKII cells and was not a substrate of human multidrug resistance protein 1 (MDR1).	Pharmacol Res Perspect. 2018 Nov 29;6(6):e00447
LLC-PK1 cells	1 µM	3.5 hours	To evaluate the passive permeability and transport properties of Risdiplam. Results showed that Risdiplam had an average passive permeability of around 350 nm/s in LLC-PK1 cells and was not a substrate of human multidrug resistance protein 1 (MDR1).	Pharmacol Res Perspect. 2018 Nov 29;6(6):e00447

Mice, rats, and monkeys	SMA mouse models (C/C-allele and SMN Δ7)	Oral or intraperitoneal injection	0.1-10 mg/kg	Once daily for 7-219 days	To assess the tissue distribution of Risdiplam and its effect on SMN protein expression in animal models. Results showed that Risdiplam had similar drug levels in plasma, muscle, and brain, and increased SMN protein levels in both CNS and peripheral tissues.	Pharmacol Res Perspect. 2018 Nov 29;6(6):e00447
Human	5q-spinal muscular atrophy (SMA)	Oral	5 mg daily	Once daily for 12 months	To evaluate the effect of Risdiplam on swallowing function in adult SMA patients. Results showed significant improvement in subjective swallowing quality after 12 months of treatment.	J Neurol. 2024 May;271(5):2649-2657
Cynomolgus monkeys	Cynomolgus monkey retinal toxicity model	Oral		Daily administration for 39 weeks	To evaluate retinal toxicity of Risdiplam in cynomolgus monkeys. Peripheral photoreceptor degeneration was observed at mid and high doses, and MMD in the central retina at high dose. These changes were partially reversible in the high-dose group.	Ann Clin Transl Neurol. 2021 Jan;8(1):54-65
Human infants	Type 1 spinal muscular atrophy (SMA)	Oral		At least 36 months	To evaluate the long-term efficacy and safety of risdiplam versus nusinersen in children with type 1 SMA. Results showed that compared with nusinersen, risdiplam treatment was associated with a 78% reduction in the rate of death, an 81% reduction in the rate of death or permanent ventilation, and a 57% reduction in the rate of serious adverse events. Additionally, children treated with risdiplam had higher response rates on the Hammersmith Infant Neurological Examination, Module 2 and the Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders.	Adv Ther. 2024 Jun;41(6):2414-2434

{[proInfo.proName]}

CAS No.: 1825352-65-5

{[proInfo.proName]}

CAS No.: 1825352-65-5

Alternative Products

Product Details of Risdiplam

Safety of Risdiplam

Related Pathways of Risdiplam

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT03040635	Healthy Volunteers	Phase 1	Completed	-	United States, California ... More >> Collaborative Neuroscience Network, Inc. Garden Grove, California, United States, 92845 Less <<
NCT02908685	Muscular Atrophy, Spinal	Phase 2 Phase 3	Active, not recruiting	July 12, 2020	-
NCT02633709	Spinal Muscular Atrophy	Phase 1	Completed	-	Netherlands ... More >> Pra International Group B.V Groningen, Netherlands, 9728 NZ Less <<
NCT03036501	Healthy	Phase 1	Completed	-	Netherlands ... More >> Pra International Group B.V Groningen, Netherlands, 9728 NZ Less <<
NCT02913482	Muscular Atrophy, Spinal	PHASE2	COMPLETED	2023-12-22	Stanford University Medical Ce... More >>nter, Palo Alto, California, 94304, United States\|Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, Illinois, 60611, United States\|Boston Childrens Hospital, Boston, Massachusetts, 02115, United States\|Columbia University Medical Center; The Neurological Institute of New York, New York, New York, 10032, United States\|UZ Gent, Gent, 9000, Belgium\|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium\|Chr de La Citadelle, Liège, 4000, Belgium\|Instituto de Puericultura E Pediatria Martag?o Gesteira, Rio de Janeiro, RJ, CEP 21941-912, Brazil\|Hospital das Clinicas - FMUSP_X; Neurologia, Sao Paulo, SP, 05403-000, Brazil\|Peking University First Hospital, Beijing City, 100034, China\|Children's Hospital of Fudan University, Shanghai, 201102, China\|Clinical Medical Center Zagreb; University Hospital Rebro Department of Paediatrics, Zagreb, 10000, Croatia\|Hopital Femme Mere Enfant; Medecine Physique et Readaptation Pediatrique ? L?ESCALE, Bron, 69677, France\|Hopital Armand Trousseau, Paris, 75571, France\|IRCCS Ospedale Pediatrico Bambino Gesù; U.O. Malattie Neuromuscolari e Neurodegenerative, Roma, Lazio, 00165, Italy\|Policlinico Agostino Gemelli; Dipartimento di Neuropsichiatria Infantile, Roma, Lazio, 00168, Italy\|IRCCS Istituto Giannina Gaslini; U.O.S.D. Centro di Miologia e Patologie Neurodegenerative, Genova, Liguria, 16147, Italy\|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Unità Operativa Complessa di Neurologia, Milano, Lombardia, 20122, Italy\|Fondazione IRCCS Istituto Neurologico ?Carlo Besta?; UO di Neurologia dello Sviluppo, Milano, Lombardia, 20133, Italy\|Hyogo Medical University Hospital, Hyogo, 663-8501, Japan\|Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology, Gda?sk, 80-952, Poland\|The Children?s Memorial Health Institute Department of Neurology and Epileptology, Warszawa, 04-730, Poland\|Russian Children Neuromuscular Center of Veltischev, Moscow, Moskovskaja Oblast, 125412, Russian Federation\|King Faisal Specialist Hospital and Research Centre Building, Riyadh, 11211, Saudi Arabia\|Institute for Mother and Child Dr. Vukan Cupic, Belgrade, 11000, Serbia\|Hospital Sant Joan De Deu, Esplugues De Llobregas, Barcelona, 08950, Spain\|Hospital Universitari Vall d'Hebron; Area Genética Clínica y Molecular, Barcelona, 08035, Spain\|Hospital Universitario Virgen del Rocio, Sevilla, 41013, Spain\|Universit?ts-Kinderspital (UKBB) Neurop?diatrie, Basel, 4005, Switzerland\|Hacettepe University, School of Medicine; Pediatrics Department; Pediatrics Child Neurology Unit, Ankara, 06100, Turkey\|Hospital Yeditepe University Kozyatagi; Pediatry, Atasehir- Istanbul, 34752, Turkey\|Ams of Ukraine; Inst. of Neurology, Psychiatry & Narcology, Kharkov, 61068, Ukraine Less <<
NCT03032172	Spinal Muscular Atrophy	PHASE2	ACTIVE_NOT_RECRUITING	2025-02-25	Stanford University Medical Ce... More >>nter, Palo Alto, California, 94304, United States\|Nemours Children's Hospital, Orlando, Florida, 32827, United States\|Boston Childrens Hospital, Boston, Massachusetts, 02115, United States\|Columbia University Medical Center, New York, New York, 10032, United States\|UZ Gent, Gent, 9000, Belgium\|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium\|Hopital Femme Mere Enfant, Bron, 69677, France\|Hopital Roger Salengro, Lille, 59037, France\|CHRU de Montpellier, Hopital Gui de Chauliac, Montpellier, 34295, France\|H?pital Necker-Enfants Malades, Paris, 75015, France\|Hopital des Enfants, Toulouse, 31059, France\|Universit?tsklinikum Essen, Essen, 45147, Germany\|Universit?tsklinikum Freiburg, Freiburg, 79106, Germany\|IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Lazio, 00165, Italy\|Policlinico Agostino Gemelli, Roma, Lazio, 00168, Italy\|IRCCS Istituto Giannina Gaslini, Genova, Liguria, 16147, Italy\|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Lombardia, 20122, Italy\|UOSD Malattie Neurodegenerative, Messina, Sicilia, 98125, Italy\|UMC Utrecht, Utrecht, 3584 CX, Netherlands\|Klinika Neurologii I Wydzialu Lekarskiego WUM w Warszawie, Warszawa, 02-097, Poland\|Universit?ts-Kinderspital (UKBB) Neurop?diatrie, Basel, 4005, Switzerland\|Birmingham Heartlands Hospital, Birmingham, B9 5SS, United Kingdom\|UCL Institute of Child Health & Great Ormond Street Hospital for Children, London, WC1N 1EH, United Kingdom\|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE1 4LP, United Kingdom Less <<
NCT04256265	Muscular Atrophy, Spinal		APPROVED_FOR_MARKETING	-	Arkansas Children's Hospital; ... More >>Pediatrics, Little Rock, Arkansas, 72202, United States\|Children's Hospital Los Angeles, Los Angeles, California, 90010, United States\|Stanford University, Palo Alto, California, 94304, United States\|University of Colorado in Denver-Anschutz Medical Campus, Aurora, Colorado, 80045, United States\|Nemours Children's Hospital, Orlando, Florida, 32827, United States\|Comprehensive NeuroBehavioral Institute, Plantation, Florida, 33317, United States\|Rare Disease Research, LLC, Atlanta, Georgia, 30318, United States\|Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, Illinois, 60611, United States\|Southern Illinois University, School of Medicine, Springfield, Illinois, 62702, United States\|Indiana Hemophilia & Thrombosis center, Indianapolis, Indiana, 46260, United States\|University of Iowa, Iowa City, Iowa, 52242, United States\|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States\|University of Louisville, Louisville, Kentucky, 40202, United States\|Massachusetts General Hospital; Neurology, Boston, Massachusetts, 02114, United States\|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, 49503, United States\|University of Mississippi Medical Center; Neurology, Jackson, Michigan, 39216, United States\|Gillette Spcl Children's Clin; Pediatric Endocrinology, Saint Paul, Minnesota, 55101, United States\|St. Louis Children Hospital, Saint Louis, Missouri, 63110, United States\|Goryeb Children's Hospital, Morristown, New Jersey, 07960, United States\|Northwell Hospital, New Hyde Park, New York, 11042, United States\|NYU Langone, New York, New York, 10003, United States\|University of Rochester Medical Center, Rochester, New York, 14642, United States\|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States\|Akron Childrens Hospital, Akron, Ohio, 44308, United States\|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States\|University of Virginia Children's Hospital; Developmental, Charlottesville, Virginia, 22903, United States\|University of Wisconsin American Family; Childrens Hospital, Madison, Wisconsin, 53792, United States\|Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, 53201, United States\|Medical College of Wisconsin, Inc., Milwaukee, Wisconsin, 53226-3596, United States Less <<
NCT05808764	Muscular Atrophy, Spinal	PHASE2	RECRUITING	2025-08-31	Ann and Robert H. Lurie Childr... More >>en Hospital of Chicago, Chicago, Illinois, 60611, United States\|University Of Michigan, Ann Arbor, Michigan, 48109, United States\|Clinic for Special Children., Gordonville, Pennsylvania, 17529, United States\|Hopital Universitaire des Enfants Reine Fabiola, Bruxelles, 1020, Belgium\|CHR Citadelle, Liege, 4000, Belgium\|Children'S Hospital of Eastern Ontario, Ottawa, Ontario, K1H 8L1, Canada\|Universitatsklinikum Essen, Essen, 45147, Germany\|Fondazione Serena Onlus - CENTRO CLINICO NEMO, Milano, Emilia-Romagna, 20162, Italy\|Fondazione Policlinico Univeristario A. Gemelli, Roma, Emilia-Romagna, 00168, Italy\|UMC Utrecht, Utrecht, 3508, Netherlands\|OUS (Oslo University Hospital), Rikshospitalet, Oslo, 0372, Norway\|Uniwersyteckie Centrum Kliniczne, Gda?sk, 80-952, Poland\|Instytut Pomnik - Centrum Zdrowia Dziecka, Warszawa, 04-730, Poland Less <<
NCT03779334	Muscular Atrophy, Spinal	PHASE2	ACTIVE_NOT_RECRUITING	2027-03-31	Nemours Children's Hospital, O... More >>rlando, Florida, 32827, United States\|Sydney Children's Hospital; CENTRE FOR CHILD HEALTH RESEARCH & INNOVATION (CHeRI), Randwick, New South Wales, 2031, Australia\|Chr de La Citadelle, Liège, 4000, Belgium\|Hospital das Clinicas - FMUSP_X; Neurologia, Sao Paulo, SP, 05403-000, Brazil\|Szpital Gdanskiego Uniwersytetu Medycznego; Clinic of developmental neurology, Gda?sk, 80-952, Poland\|Russian Children Neuromuscular Center of Veltischev, Moscow, Moskovskaja Oblast, 125412, Russian Federation\|Kaohsiung Medical University Chung-Ho Hospital; Pediatric Neurology, Kaohsiung, 807, Taiwan Less <<
NCT05522361	Spinal Muscular Atrophy	PHASE4	ACTIVE_NOT_RECRUITING	2026-06-15	Clinic for Special Children, S... More >>trasburg, Pennsylvania, 17579, United States Less <<
NCT05219487	Spinal Muscular Atrophy		RECRUITING	2025-12-31	The Ohio State University Wexn... More >>er Medical Center, Columbus, Ohio, 43210, United States Less <<
NCT03920865	Muscular Atrophy, Spinal	PHASE1	COMPLETED	2020-01-02	Clinical Pharmacology of Miami... More >>, Inc., Miami, Florida, 33014, United States\|Orlando Clinical Research Center, Orlando, Florida, 32809, United States\|American Research Corporation Inc., San Antonio, Texas, 78215, United States Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed